On Tuesday, Pacific Biosciences of California Inc (NASDAQ: PACB) was 5.10% up from the session before settling in for the closing price of $1.57. A 52-week range for PACB has been $0.85 – $2.46.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -23.55%. When this article was written, the company’s average yearly earnings per share was at -64.88%. With a float of $270.83 million, this company’s outstanding shares have now reached $301.85 million.
Pacific Biosciences of California Inc (PACB) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Pacific Biosciences of California Inc stocks. The insider ownership of Pacific Biosciences of California Inc is 10.29%, while institutional ownership is 52.62%. The most recent insider transaction that took place on Aug 18 ’25, was worth 35,182. In this transaction an insider of this company sold 26,836 shares at a rate of $1.31, taking the stock ownership to the 1,920,035 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Officer proposed sale 26,836 for $1.31, making the entire transaction worth $35,174.
Pacific Biosciences of California Inc (PACB) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.2 earnings per share (EPS) during the time that was less than consensus figure (set at -0.17) by -0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -64.88% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.32% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
You can see what Pacific Biosciences of California Inc (PACB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.18, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
The latest stats from [Pacific Biosciences of California Inc, PACB] show that its last 5-days average volume of 5.56 million was inferior to 9.26 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 15.50%.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 40.98%, which indicates a significant increase from 14.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1718 in the past 14 days, which was higher than the 0.1190 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6047, while its 200-day Moving Average is $1.3738. Now, the first resistance to watch is $1.7055. This is followed by the second major resistance level at $1.7610. The third major resistance level sits at $1.8520. If the price goes on to break the first support level at $1.5590, it is likely to go to the next support level at $1.4680. The third support level lies at $1.4125 if the price breaches the second support level.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
There are 301,907K outstanding shares of the company, which has a market capitalization of 498.14 million. As of now, sales total 154,010 K while income totals -309,850 K. Its latest quarter income was 38,440 K while its last quarter net income were -38,000 K.
